ifosfamide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Seventy-two patients with recurrent or refractory malignant lymphoproliferative diseases were treated with MIME combination chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) and concurrent mesna to prevent urothelial toxicity; 41 patients had high/intermediate-grade non-Hodgkin's lymphoma (NHL), 18 low-grade NHL/chronic lymphocytic leukemia (CLL), and 13 Hodgkin's disease (HD)." | 5.07 | MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study. ( Brincker, H; Mirza, MR, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siegert, W | 1 |
Nerl, C | 1 |
Engelhard, M | 1 |
Brittinger, G | 1 |
Tiemann, M | 1 |
Parwaresch, R | 1 |
Heinz, R | 1 |
Huhn, D | 1 |
Bosanquet, AG | 1 |
McCann, SR | 1 |
Crotty, GM | 1 |
Mills, MJ | 1 |
Catovsky, D | 1 |
Mirza, MR | 1 |
Brincker, H | 1 |
3 trials available for ifosfamide and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1994 |
Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; C | 1995 |
MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Ifo | 1991 |